Raised B-type natriuretic peptide predicts implantable cardioverter-defibrillator therapy in patients with ischaemic cardiomyopathy.
Klingenberg
R
R
Zugck
C
C
Becker
R
R
Schellberg
D
D
Heinze
G
G
Kell
R
R
Remppis
A
A
Schoels
W
W
Katus
H A
HA
Dengler
T J
TJ
D015415:Biomarkers / Q000097:blood; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D005260:Female; D006333:Heart Failure / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood*; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D018579:Patient Selection; D013610:Tachycardia / Q000517:prevention & control*
D015415:Biomarkers; D020097:Natriuretic Peptide, Brain